Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for MariMed Inc. (MRMD : OTC)

• Company Description    MariMed Inc. is a multi-state cannabis operator. The Company develops, owns and manages seed to sale state-licensed cannabis facilities, which are models in horticultural principles, cannabis cultivation, cannabis-infused products and dispensary operations. Its products and brands, includes Betty's Eddies(R), Nature's Heritage(TM), Bourne Baking Co. and K-Fusion(R). MariMed Inc. is based in NORWOOD, Mass. Number of Employees: 832

• Price / Volume Information    Yesterday's Closing Price: $0.14 Daily Weekly Monthly 20 Day Moving Average: 2,540,772 shares Shares Outstanding: 390.43 (millions) Market Capitalization: $53.65 (millions) Beta: 3.01 52 Week High: $0.23 52 Week Low: $0.07 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 5.69% 3.83% 12 Week 97.70% 79.58% Year To Date 18.65% 10.64%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 10 Oceana Way - Norwood,MA 02062 USA ph: 781-277-0007 fax: - ir@marimedinc.com http://www.marimedinc.com

• General Corporate Information    Officers Jon R. Levine - Chief Executive Officer and President Edward Gildea - Chairman of the Board and Director Mario Pinho - Chief Financial Officer David Allen - Director Eva Selhub - Director Peer Information MariMed Inc. (BJCT) MariMed Inc. (CADMQ) MariMed Inc. (APNO) MariMed Inc. (UPDC) MariMed Inc. (IMTIQ) MariMed Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 56782V107 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/05/25 Share - Related Items Shares Outstanding: 390.43 Most Recent Split Date: (:1) Beta: 3.01 Market Capitalization: $53.65 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.00 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.02 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/05/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.92 Price/Cash Flow: 6.37 Price / Sales: 0.34 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 100.00% Sales Growth vs. Year Ago Period: -2.05% vs. Previous Quarter: 4.36% ROE 06/30/25 - -10.52 03/31/25 - -10.21 12/31/24 - -4.98 ROA 06/30/25 - -3.10 03/31/25 - -3.12 12/31/24 - -1.59 Current Ratio 06/30/25 - 1.12 03/31/25 - 1.05 12/31/24 - 1.10 Quick Ratio 06/30/25 - 0.36 03/31/25 - 0.37 12/31/24 - 0.41 Operating Margin 06/30/25 - -4.10 03/31/25 - -4.13 12/31/24 - -2.09 Net Margin 06/30/25 - -10.14 03/31/25 - -10.33 12/31/24 - -7.70 Pre-Tax Margin 06/30/25 - -4.30 03/31/25 - -4.40 12/31/24 - -2.51 Book Value 06/30/25 - 0.15 03/31/25 - 0.15 12/31/24 - 0.16 Inventory Turnover 06/30/25 - 2.66 03/31/25 - 2.81 12/31/24 - 2.96 Debt-to-Equity 06/30/25 - 1.25 03/31/25 - 1.21 12/31/24 - 1.20 Debt-to-Capital 06/30/25 - 55.57 03/31/25 - 54.66 12/31/24 - 54.52

Powered by Zacks Investment Research ©